F. Abbas et al., INVESTIGATION INTO THE ROLE OF CYCLOOXYGENASE PRODUCTS IN THE BRADYKININ RESPONSE ON ISOLATED HUMAN MYOMETRIUM AND UMBILICAL ARTERY, Immunopharmacology, 33(1-3), 1996, pp. 123-126
The aim of this study was to investigate the response to bradykinin (B
K) on human myometrium and umbilical artery with respect to cyclo-oxyg
enase (GO) products. Dose/concentration response curves to BK were per
formed +/-2.79 mu M indomethacin. On human myometrium the response to
BK (0.001-50 nmol) was biphasic and consisted of a dose-related increa
se in myometrial tension which was followed by a period of inhibition
of myogenic activity. In tissues from P donors the presence of indomet
hacin had no significant effect on the excitatory response, but the in
hibitory component of the response was reduced. In tissues from NP don
ors indomethacin significantly enhanced the BK effect at higher doses
and the inhibitory component of the response was reduced. On the HUA c
umulative addition of BK (1-1000 nM) resulted in dose dependent constr
iction with desensitisation at the highest dose (EC(50) = 38 nM). The
presence of indomethacin had no significant effect on BK response on H
UA. These findings suggest that CO products contribute significantly t
o response to BK on the human myometrium but not on HUA and that diffe
rent CO products are produced by P and NP tissue.